Robert McRae

Nessuna posizione attualmente

Patrimonio netto: 1 735 $ in data 31/03/2024

40 anni

Health Technology

Consumer Services

Precedenti posizioni note di Robert McRae

Società	Posizione	Inizio	Fine
PALISADE BIO, INC.	Chief Operating Officer	01/12/2021	01/05/2023
VIRACTA THERAPEUTICS, INC.	Corporate Officer/Principal	01/09/2017	-
Viracta Subsidiary, Inc. Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.	Chief Operating Officer	01/12/2018	-

Wright State University (Ohio)

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Operating Officer	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
VIRACTA THERAPEUTICS, INC.	Health Technology
PALISADE BIO, INC.	Health Technology

Aziende private	1
Viracta Subsidiary, Inc. Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.	Health Technology

Aziende private

Health Technology